Found "Health Policies": 996 results
Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6
Abstract
BACKGROUND:
Pegylated interferon alpha 2a, alpha 2b and ribavirin have been included to the National List of Essential Medicines (NLEM) for treatment of only chronic hepatitis C genotypes 2 and 3 in Thailand. This reimbursement policy has not covered for other genotypes of hepatitis
Economic evaluation of policy options for dialysis in end-stage renal disease patients under the universal health coverage in Indonesia
Abstract
Objectives
This study aims to assess the value for money and budget impact of offering hemodialysis (HD) as a first-line treatment, or the HD-first policy, and the peritoneal dialysis (PD) first policy compared to a supportive care option in patients with end-stage renal disease (ESRD)
Developing and testing quality indicators for the Thai Quality and Outcomes Framework
Primary care serves as an entry point in the Thai health care system. Whilst effective interventions are provided in the primary care setting, the quality of the services have not been measured or tracked. A number of initiatives were undertaken to improve primary health care quality including the u
To include or not include: renal dialysis policy in the era of universal health coverage
SUMMARY POINTS
• End stage renal disease (ESRD) is a life-threatening condition that results in most patients requiring a lifetime of high cost renal dialysis
• Governments have grappled with the political, economic, and ethical challenges of providing treatment with their available budgets
•
Dispelling the myths of providing dialysis in low- and middle-income countries
Public policy for kidney replacement therapy eludes most low- and middle-income countries owing to the seemingly low number of cases and high cost. Countries such as Thailand have shown that public health authorities can effectively provide treatment and elevate health care for populations by overco
Prioritizing critical-care resources in response to COVID-19: lessons from the development of Thailand’s Triage protocol
Abstract
As COVID-19 ravages the world, many countries are faced with the grim reality of not having enough critical-care resources to go around. Knowing what could be in store, the Thai Ministry of Public Health called for the creation of an explicit protocol to determine how these resources are
A protocol for a systematic literature review of economic evaluation studies of interventions to address antimicrobial resistance
Abstract
Background
Antimicrobial resistance (AMR) is accelerated by the widespread and often indiscriminate use of antimicrobials in humans, animals, and the environment. In 2015, the World Health Organization recognised AMR as one of the top ten global health threats, due to its potential to n
Using an experiment among clinical experts to determine the cost and clinical impact of rapid whole exome sequencing in acute pediatric settings
Introduction
Genetic disorders in children contribute to acute hospitalizations and mortality. Early diagnosis is critical for better outcomes but difficult to achieve due to atypical presentations for thousands of potential genetic diseases. Next-generation sequencing (NGS) is a precision
Navigating HTA implementation: a review of Indonesia’s revised HTA guideline
Indonesia issued the 2017 health technology assessment (HTA) guideline to facilitate researchers conducting economic evaluations based on standardised principles. However, our evaluation revealed no significant differences in adherence to its recommendation between HTA studies conducted before and a
The Economic Evaluation of Medical Devices: Challenges (2014)
Pritaporn Kingkaew BPharm, MSc*,
Yot Teerawattananon MD, PhD*
* Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand
While many of the principles that guide the economic evaluation of medical devices are somewhat similar to those that guide the evaluation of other
10 / Page